340B Drug Pricing Program Oversight and Administration
House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
Stuart Wright, Deputy Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
Testimony Statement PDF, 76.4 KB